Recruiting
Phase 3

Buccal Film vs. IV Palonosetron

Sponsor:

Xiamen LP Pharmaceutical Co., Ltd

Code:

NCT05199818

Conditions

Chemotherapy-induced Nausea and Vomiting

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palonosetron HCl Buccal Film 0.5 mg

IV Palonosetron 0.25 mg

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Xiamen LP Pharmaceutical Co., Ltd on 2023-01-20.